TSR-011: A potent inhibitor of ALK with activity in crizotinib-resistant tumor models in phase 1-2 development for ALK plus NSCLC
EUROPEAN JOURNAL OF CANCER(2013)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined